ADPT — Adaptive Biotechnologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Adaptive Biotechnologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	577	688	353	498	346
Net Total Accounts Receivable
Net Total Receivables	12.7	10	17.4	40.1	38
Total Inventory
Prepaid Expenses
Total Current Assets	613	727	403	562	410
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	60.4	139	173	164	120
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	912	1,116	923	857	661
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	78.3	105	114	110	88
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	341	373	319	392	353
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	571	743	604	464	308
Total Liabilities & Shareholders' Equity	912	1,116	923	857	661
Total Common Shares Outstanding